Hiroaki Tanioka

Kurashiki, 7010192, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Residual Platinum-Induced Neuropathy and the Feasibility of Second-Line Paclitaxel-Ramucirumab Therapy in Advanced Gastric Cancer: Prospective Multicenter Evidence from Japan.

Residual Platinum-Induced Neuropathy and the Feasibility of Second-Line Paclitaxel-Ramucirumab Therapy in Advanced Gastric Cancer: Prospective Multicenter Evidence from Japan.

Journal: Cancers

Published: June 16, 2026

Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial.

Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial.

Journal: Communications medicine

Published: November 04, 2025

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.

Journal: ESMO open

Published: July 04, 2023

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles.

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles.

Journal: Molecular cancer

Published: May 19, 2023

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer.

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer.

Journal: Oncology letters

Published: August 12, 2022

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.

Journal: Oncology

Published: August 10, 2022

Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen.

Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen.

Journal: Anticancer research

Published: March 04, 2022

Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study.

Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 30, 2022

Erratum: Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study.

Erratum: Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study.

Journal: Molecular and clinical oncology

Published: December 09, 2021

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.

Journal: BMC cancer

Published: May 19, 2021

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.

Journal: Future science OA

Published: May 04, 2021

Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.

Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.

Journal: Clinical epigenetics

Published: March 02, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026